104948,1,Admission,O
104948,1,Date,O
104948,1,:,O
104948,1,[,O
104948,1,**2154-12-14**,O
104948,1,],O
104948,1,Discharge,O
104948,1,Date,O
104948,1,:,O
104948,1,[,O
104948,1,**2155-1-4**,O
104948,1,],O
104948,1,Date,O
104948,1,of,O
104948,1,Birth,O
104948,1,:,O
104948,1,[,O
104948,1,**2074-11-21**,O
104948,1,],O
104948,1,Sex,O
104948,1,:,O
104948,1,M,O
104948,1,Service,O
104948,1,:,O
104948,1,MEDICINE,O
104948,1,Allergies,O
104948,1,:,O
104948,1,Sulfa,B-Drug
104948,1,(,I-Drug
104948,1,Sulfonamides,I-Drug
104948,1,),I-Drug
104948,1,Attending,O
104948,1,:,O
104948,1,[,O
104948,1,**First,O
104948,1,Name3,O
104948,1,(,O
104948,1,LF,O
104948,1,),O
104948,1,1973**,O
104948,1,],O
104948,1,Chief,O
104948,1,Complaint,O
104948,1,:,O
104948,1,Delta,O
104948,1,MS,O
104948,1,",",O
104948,1,respiratory,O
104948,1,distress,O
104948,1,Major,O
104948,1,Surgical,O
104948,1,or,O
104948,1,Invasive,O
104948,1,Procedure,O
104948,1,:,O
104948,1,R,O
104948,1,chest,O
104948,1,tube,O
104948,1,place,O
104948,1,Intubation,O
104948,1,and,O
104948,1,mechanical,O
104948,1,ventilation,O
104948,1,R,O
104948,1,IJ,O
104948,1,central,O
104948,1,line,O
104948,1,placed,O
104948,1,L,O
104948,1,SC,O
104948,1,central,O
104948,1,line,O
104948,1,placed,O
104948,1,PICC,O
104948,1,line,O
104948,1,placed,O
104948,1,History,O
104948,1,of,O
104948,1,Present,O
104948,1,Illness,O
104948,1,:,O
104948,1,80yo,O
104948,1,M,O
104948,1,with,O
104948,1,h/o,O
104948,1,hyperlipidemia,O
104948,1,",",O
104948,1,RA,O
104948,1,",",O
104948,1,new,O
104948,1,diagnosis,O
104948,1,of,O
104948,1,glioblastoma,B-Reason
104948,1,multiforme,I-Reason
104948,1,(,O
104948,1,grade,O
104948,1,4,O
104948,1,),O
104948,1,p/w,O
104948,1,altered,O
104948,1,mental,O
104948,1,status,O
104948,1,and,O
104948,1,respiratory,O
104948,1,distress,O
104948,1,.,O
104948,1,He,O
104948,1,was,O
104948,1,diagnosed,O
104948,1,in,O
104948,1,[,O
104948,1,**Month,O
104948,1,(,O
104948,1,only,O
104948,1,),O
104948,1,1096**,O
104948,1,],O
104948,1,with,O
104948,1,GBM,O
104948,1,(,O
104948,1,by,O
104948,1,biopsy,O
104948,1,),O
104948,1,in,O
104948,1,the,O
104948,1,setting,O
104948,1,of,O
104948,1,increasing,O
104948,1,confusion,O
104948,1,",",O
104948,1,memory,O
104948,1,loss,O
104948,1,.,O
104948,1,He,O
104948,1,was,O
104948,1,started,O
104948,1,in,O
104948,1,[,O
104948,1,**Month,O
104948,1,(,O
104948,1,only,O
104948,1,),O
104948,1,1096**,O
104948,1,],O
104948,1,on,O
104948,1,high,B-Reason
104948,1,dose,I-Reason
104948,1,radiation,I-Reason
104948,1,therapy,I-Reason
104948,1,at,O
104948,1,which,O
104948,1,time,O
104948,1,he,O
104948,1,was,O
104948,1,also,O
104948,1,started,O
104948,1,on,O
104948,1,high,O
104948,1,dose,O
104948,1,decadron,B-Drug
104948,1,w/,O
104948,1,q3day,O
104948,1,taper,O
104948,1,(,O
104948,1,most,O
104948,1,recently,O
104948,1,on,O
104948,1,3mg,O
104948,1,),O
104948,1,;,O
104948,1,last,O
104948,1,radiation,O
104948,1,session,O
104948,1,was,O
104948,1,late,O
104948,1,[,O
104948,1,**Month,O
104948,1,(,O
104948,1,only,O
104948,1,),O
104948,1,1096**,O
104948,1,],O
104948,1,.,O
104948,1,He,O
104948,1,also,O
104948,1,recently,O
104948,1,had,O
104948,1,a,O
104948,1,port,O
104948,1,placed,O
104948,1,through,O
104948,1,which,O
104948,1,he,O
104948,1,was,O
104948,1,receiving,O
104948,1,avastin,B-Drug
104948,1,(,O
104948,1,last,O
104948,1,2,O
104948,1,weeks,O
104948,1,ago,O
104948,1,),O
104948,1,.,O
104948,1,His,O
104948,1,family,O
104948,1,reports,O
104948,1,mildly,O
104948,1,productive,O
104948,1,cough,O
104948,1,(,O
104948,1,cold,O
104948,1,sx,O
104948,1,),O
104948,1,beginning,O
104948,1,approximately,O
104948,1,1,O
104948,1,week,O
104948,1,ago,O
104948,1,;,O
104948,1,he,O
104948,1,had,O
104948,1,a,O
104948,1,CXR,O
104948,1,3-4,O
104948,1,days,O
104948,1,ago,O
104948,1,which,O
104948,1,reportedly,O
104948,1,was,O
104948,1,negative,O
104948,1,for,O
104948,1,pneumonia,B-Reason
104948,1,and,O
104948,1,took,O
104948,1,atovaquone,B-Drug
104948,1,.,O
104948,1,.,O
104948,1,After,O
104948,1,the,O
104948,1,onset,O
104948,1,of,O
104948,1,these,O
104948,1,pulmonary,O
104948,1,symptoms,O
104948,1,",",O
104948,1,he,O
104948,1,later,O
104948,1,developed,O
104948,1,left,B-Reason
104948,1,knee,I-Reason
104948,1,``,I-Reason
104948,1,bursitis,I-Reason
104948,1,``,O
104948,1,last,O
104948,1,week,O
104948,1,for,O
104948,1,which,O
104948,1,he,O
104948,1,received,O
104948,1,injection,O
104948,1,most,O
104948,1,recently,O
104948,1,yesterday,O
104948,1,by,O
104948,1,PCP,O
104948,1,(,O
104948,1,presumably,O
104948,1,steroid,B-Drug
104948,1,injection,O
104948,1,),O
104948,1,.,O
104948,1,He,O
104948,1,had,O
104948,1,largely,O
104948,1,been,O
104948,1,bed,O
104948,1,bound,O
104948,1,over,O
104948,1,the,O
104948,1,last,O
104948,1,few,O
104948,1,days,O
104948,1,[,O
104948,1,**1-4**,O
104948,1,],O
104948,1,to,O
104948,1,left,O
104948,1,knee,O
104948,1,pain,O
104948,1,.,O
104948,1,Beginning,O
104948,1,this,O
104948,1,morning,O
104948,1,",",O
104948,1,he,O
104948,1,was,O
104948,1,very,O
104948,1,exhausted,O
104948,1,.,O
104948,1,He,O
104948,2,took,O
104948,2,a,O
104948,2,nap,O
104948,2,this,O
104948,2,morning,O
104948,2,and,O
104948,2,when,O
104948,2,he,O
104948,2,awoke,O
104948,2,",",O
104948,2,he,O
104948,2,was,O
104948,2,confused,O
104948,2,",",O
104948,2,somnolent,O
104948,2,",",O
104948,2,lethargic,O
104948,2,.,O
104948,2,His,O
104948,2,wife,O
104948,2,called,O
104948,2,EMS,O
104948,2,and,O
104948,2,he,O
104948,2,was,O
104948,2,transferred,O
104948,2,to,O
104948,2,[,O
104948,2,**Hospital1,O
104948,2,18**,O
104948,2,],O
104948,2,ED,O
104948,2,.,O
104948,2,En,O
104948,2,route,O
104948,2,to,O
104948,2,the,O
104948,2,ED,O
104948,2,",",O
104948,2,he,O
104948,2,was,O
104948,2,noted,O
104948,2,to,O
104948,2,be,O
104948,2,in,O
104948,2,a.fib,B-Reason
104948,2,with,I-Reason
104948,2,RVR,I-Reason
104948,2,for,O
104948,2,which,O
104948,2,he,O
104948,2,received,O
104948,2,diltiazem,B-Drug
104948,2,.,O
104948,2,.,O
104948,2,In,O
104948,2,the,O
104948,2,ED,O
104948,2,initial,O
104948,2,vitals,O
104948,2,were,O
104948,2,T,O
104948,2,96.7,O
104948,2,HR,O
104948,2,112,O
104948,2,BP,O
104948,2,105/67,O
104948,2,RR,O
104948,2,28,O
104948,2,O2,O
104948,2,sat,O
104948,2,85,O
104948,2,%,O
104948,2,RA,O
104948,2,.,O
104948,2,CXR,O
104948,2,showed,O
104948,2,multifocal,B-Reason
104948,2,PNA,I-Reason
104948,2,at,O
104948,2,RUL,O
104948,2,",",O
104948,2,RLL,O
104948,2,",",O
104948,2,LLL,O
104948,2,.,O
104948,2,He,O
104948,2,was,O
104948,2,placed,O
104948,2,on,O
104948,2,NRB,O
104948,2,and,O
104948,2,shortly,O
104948,2,thereafter,O
104948,2,O2,O
104948,2,sats,O
104948,2,again,O
104948,2,dropped,O
104948,2,to,O
104948,2,the,O
104948,2,80s,O
104948,2,",",O
104948,2,thus,O
104948,2,he,O
104948,2,was,O
104948,2,intubated,O
104948,2,4:30,O
104948,2,pm,O
104948,2,.,O
104948,2,Blood,O
104948,2,cultures,O
104948,2,were,O
104948,2,drawn,O
104948,2,and,O
104948,2,he,O
104948,2,received,O
104948,2,levofloxacin,B-Drug
104948,2,750g,O
104948,2,IV,O
104948,2,x1,O
104948,2,",",O
104948,2,vancomycin,B-Drug
104948,2,1g,O
104948,2,IV,O
104948,2,x1,O
104948,2,",",O
104948,2,ceftriaxone,B-Drug
104948,2,1g,O
104948,2,IV,O
104948,2,x1,O
104948,2,",",O
104948,2,and,O
104948,2,azithromycin,B-Drug
104948,2,500mg,O
104948,2,x1,O
104948,2,.,O
104948,2,He,O
104948,2,also,O
104948,2,received,O
104948,2,10mg,O
104948,2,IV,O
104948,2,decadron,B-Drug
104948,2,.,O
104948,2,He,O
104948,2,was,O
104948,2,initially,O
104948,2,normotensive,O
104948,2,",",O
104948,2,but,O
104948,2,dropped,B-Reason
104948,2,pressure,I-Reason
104948,2,at,O
104948,2,6:30,O
104948,2,pm,O
104948,2,into,O
104948,2,70s,O
104948,2,requiring,O
104948,2,initiation,O
104948,2,of,O
104948,2,phenylephrine,B-Drug
104948,2,gtt,O
104948,2,.,O
104948,2,Over,O
104948,2,his,O
104948,2,entire,O
104948,2,ED,O
104948,2,course,O
104948,2,",",O
104948,2,received,O
104948,2,total,O
104948,2,5L,O
104948,2,NS,B-Drug
104948,2,.,O
104948,2,.,O
104948,2,Head,O
104948,2,CT,O
104948,2,demonstrated,O
104948,2,``,O
104948,2,no,O
104948,2,new,O
104948,2,findings,O
104948,2,'',O
104948,2,and,O
104948,2,was,O
104948,2,reportedly,O
104948,2,reviewed,O
104948,2,by,O
104948,2,[,O
104948,2,**Hospital1,O
104948,2,18**,O
104948,2,],O
104948,2,neurosurgery,O
104948,2,however,O
104948,2,there,O
104948,2,is,O
104948,2,no,O
104948,2,note,O
104948,2,in,O
104948,2,chart/OMR,O
104948,2,.,O
104948,2,Additionally,O
104948,2,he,O
104948,2,was,O
104948,2,seen,O
104948,2,by,O
104948,2,his,O
104948,2,neurologist,O
104948,2,who,O
104948,2,follows,O
104948,2,him,O
104948,2,at,O
104948,2,[,O
104948,2,**Hospital1,O
104948,2,2025**,O
104948,2,],O
104948,2,",",O
104948,2,however,O
104948,2,there,O
104948,2,is,O
104948,2,no,O
104948,2,documentation,O
104948,2,of,O
104948,2,this,O
104948,2,.,O
104948,2,Past,O
104948,2,Medical,O
104948,2,History,O
104948,2,:,O
104948,2,#,O
104948,2,Grade,O
104948,2,4,O
104948,2,glioblastoma,B-Reason
104948,2,multiforme,I-Reason
104948,2,left,O
104948,2,temporal,O
104948,2,lobe,O
104948,2,;,O
104948,2,s/p,O
104948,2,high,B-Reason
104948,2,dose,I-Reason
104948,2,radiotherapy,I-Reason
104948,2,",",O
104948,2,previously,O
104948,2,on,O
104948,2,high,O
104948,2,dose,O
104948,2,steroids,B-Drug
104948,2,",",O
104948,2,recently,O
104948,2,tapered,O
104948,2,.,O
104948,2,Recently,O
104948,2,placed,O
104948,2,Portacath,O
104948,2,with,O
104948,2,steristrips,O
104948,2,still,O
104948,2,present,O
104948,2,.,O
104948,2,#,O
104948,2,Rheumatoid,B-Reason
104948,2,arthritis,I-Reason
104948,2,;,O
104948,2,on,O
104948,2,remicade,B-Drug
104948,2,until,O
104948,2,recently,O
104948,2,#,O
104948,2,L,O
104948,2,knee,O
104948,2,bursitis,O
104948,2,#,O
104948,2,Hyperlipidemia,O
104948,2,Social,O
104948,2,History,O
104948,2,:,O
104948,2,Lives,O
104948,2,at,O
104948,2,home,O
104948,2,with,O
104948,2,wife,O
104948,2,.,O
104948,2,[,O
104948,2,**Name,O
104948,2,(,O
104948,2,NI,O
104948,2,),O
104948,2,**,O
104948,2,],O
104948,2,and,O
104948,2,daughter-in-law,O
104948,2,(,O
104948,2,who,O
104948,2,is,O
104948,2,[,O
104948,2,**Name8,O
104948,2,(,O
104948,2,MD,O
104948,2,),O
104948,2,**,O
104948,3,],O
104948,3,MD,O
104948,3,),O
104948,3,live,O
104948,3,locally,O
104948,3,.,O
104948,3,Smoking,O
104948,3,",",O
104948,3,Etoh,O
104948,3,history,O
104948,3,unknown,O
104948,3,.,O
104948,3,Family,O
104948,3,History,O
104948,3,:,O
104948,3,nc,O
104948,3,Physical,O
104948,3,Exam,O
104948,3,:,O
104948,3,S,O
104948,3,:,O
104948,3,Temp,O
104948,3,:,O
104948,3,97.2,O
104948,3,BP,O
104948,3,:,O
104948,3,99/69,O
104948,3,HR,O
104948,3,:,O
104948,3,138,O
104948,3,a.,O
104948,3,fib,O
104948,3,RR,O
104948,3,:,O
104948,3,22,O
104948,3,O2sat,O
104948,3,92,O
104948,3,%,O
104948,3,AC,O
104948,3,500/19,O
104948,3,PEEP,O
104948,3,14,O
104948,3,FiO2,O
104948,3,1.0,O
104948,3,GEN,O
104948,3,:,O
104948,3,Intubated,O
104948,3,",",O
104948,3,unresponsive,O
104948,3,on,O
104948,3,minimal,O
104948,3,sedation,O
104948,3,HEENT,O
104948,3,:,O
104948,3,Pupils,O
104948,3,pinpoint,O
104948,3,",",O
104948,3,symmetric,O
104948,3,",",O
104948,3,unresponsive,O
104948,3,to,O
104948,3,light,O
104948,3,",",O
104948,3,scleral,O
104948,3,mildy,O
104948,3,icteric,O
104948,3,",",O
104948,3,dry,O
104948,3,MM,O
104948,3,",",O
104948,3,Multiple,O
104948,3,pinpoint,O
104948,3,white,O
104948,3,plaques,O
104948,3,on,O
104948,3,roof,O
104948,3,of,O
104948,3,mouth,O
104948,3,NECK,O
104948,3,:,O
104948,3,no,O
104948,3,supraclavicular,O
104948,3,or,O
104948,3,cervical,O
104948,3,lymphadenopathy,O
104948,3,",",O
104948,3,no,O
104948,3,jvd,O
104948,3,",",O
104948,3,no,O
104948,3,carotid,O
104948,3,bruits,O
104948,3,",",O
104948,3,no,O
104948,3,thyromegaly,O
104948,3,or,O
104948,3,thyroid,O
104948,3,nodules,O
104948,3,CHEST,O
104948,3,:,O
104948,3,Portacath,O
104948,3,site,O
104948,3,right,O
104948,3,anterior,O
104948,3,chest,O
104948,3,with,O
104948,3,steri,O
104948,3,strips,O
104948,3,in,O
104948,3,place,O
104948,3,",",O
104948,3,mildly,O
104948,3,erythematous,O
104948,3,",",O
104948,3,no,O
104948,3,significant,O
104948,3,increase,O
104948,3,warmth/induration/fluctuance,O
104948,3,RESP,O
104948,3,:,O
104948,3,Clear,O
104948,3,anteriorly,O
104948,3,",",O
104948,3,decrease,O
104948,3,BS,O
104948,3,right,O
104948,3,laterally,O
104948,3,",",O
104948,3,no,O
104948,3,wheezing/rales,O
104948,3,CV,O
104948,3,:,O
104948,3,irreg,O
104948,3,irreg,O
104948,3,",",O
104948,3,no,O
104948,3,mrg,O
104948,3,appreciated,O
104948,3,ABD,O
104948,3,:,O
104948,3,nd,O
104948,3,",",O
104948,3,+b/s,O
104948,3,",",O
104948,3,soft,O
104948,3,",",O
104948,3,nt,O
104948,3,",",O
104948,3,no,O
104948,3,masses,O
104948,3,or,O
104948,3,hepatosplenomegaly,O
104948,3,EXT,O
104948,3,:,O
104948,3,1+,O
104948,3,pedal,O
104948,3,edema,O
104948,3,b/l,O
104948,3,",",O
104948,3,right,O
104948,3,foot,O
104948,3,cooler,O
104948,3,than,O
104948,3,left,O
104948,3,1+,O
104948,3,DP,O
104948,3,on,O
104948,3,right,O
104948,3,",",O
104948,3,2+,O
104948,3,DP,O
104948,3,on,O
104948,3,left,O
104948,3,",",O
104948,3,palpable,O
104948,3,PT,O
104948,3,pulses,O
104948,3,b/l,O
104948,3,",",O
104948,3,left,O
104948,3,knee,O
104948,3,with,O
104948,3,small,O
104948,3,effusion,O
104948,3,",",O
104948,3,increased,O
104948,3,warmth,O
104948,3,without,O
104948,3,significant,O
104948,3,increased,O
104948,3,erythema,O
104948,3,SKIN,O
104948,3,:,O
104948,3,appears,O
104948,3,mildly,O
104948,3,jaundiced,O
104948,3,NEURO,O
104948,3,:,O
104948,3,Downgoing,O
104948,3,toes,O
104948,3,b/l,O
104948,3,.,O
104948,3,DTRs,O
104948,3,[,O
104948,3,**Name,O
104948,3,(,O
104948,3,NI,O
104948,3,),O
104948,3,20772**,O
104948,3,],O
104948,3,throughout,O
104948,3,including,O
104948,3,biceps,O
104948,3,",",O
104948,3,patellar,O
104948,3,",",O
104948,3,achilles,O
104948,3,.,O
104948,3,Pertinent,O
104948,3,Results,O
104948,3,:,O
104948,3,ADMISSION,O
104948,3,LABS,O
104948,3,[,O
104948,3,**2154-12-14**,O
104948,3,],O
104948,3,04:45PM,O
104948,3,BLOOD,O
104948,3,WBC-6.0,O
104948,3,RBC-3.78*,O
104948,3,Hgb-11.7*,O
104948,3,Hct-34.3*,O
104948,3,MCV-91,O
104948,3,MCH-31.0,O
104948,3,MCHC-34.1,O
104948,3,RDW-13.6,O
104948,3,Plt,O
104948,3,Ct-74*,O
104948,3,[,O
104948,3,**2154-12-14**,O
104948,3,],O
104948,3,04:45PM,O
104948,3,BLOOD,O
104948,3,Neuts-80*,O
104948,3,Bands-6*,O
104948,3,Lymphs-9*,O
104948,3,Monos-3,O
104948,3,Eos-0,O
104948,3,Baso-0,O
104948,3,Atyps-0,O
104948,3,Metas-2*,O
104948,3,Myelos-0,O
104948,3,[,O
104948,3,**2154-12-14**,O
104948,3,],O
104948,3,04:45PM,O
104948,3,BLOOD,O
104948,3,Hypochr-NORMAL,O
104948,3,Anisocy-NORMAL,O
104948,3,Poiklo-NORMAL,O
104948,3,Macrocy-NORMAL,O
104948,3,Microcy-NORMAL,O
104948,3,Polychr-NORMAL,O
104948,3,[,O
104948,3,**2155-1-2**,O
104948,3,],O
104948,3,02:38AM,O
104948,3,BLOOD,O
104948,3,Plt,O
104948,3,Ct-179,O
104948,3,[,O
104948,3,**2155-1-2**,O
104948,3,],O
104948,3,02:38AM,O
104948,3,BLOOD,O
104948,3,PT-14.6*,O
104948,3,PTT-35.5*,O
104948,3,INR,O
104948,3,(,O
104948,3,PT,O
104948,3,),O
104948,3,-1.3*,O
104948,3,[,O
104948,3,**2154-12-14**,O
104948,3,],O
104948,3,04:45PM,O
104948,3,BLOOD,O
104948,3,PT-13.3,O
104948,3,PTT-31.5,O
104948,3,INR,O
104948,3,(,O
104948,3,PT,O
104948,3,),O
104948,3,-1.1,O
104948,3,[,O
104948,3,**2154-12-14**,O
104948,3,],O
104948,3,04:45PM,O
104948,3,BLOOD,O
104948,3,Plt,O
104948,4,Smr-VERY,O
104948,4,LOW,O
104948,4,Plt,O
104948,4,Ct-74*,O
104948,4,[,O
104948,4,**2154-12-14**,O
104948,4,],O
104948,4,04:45PM,O
104948,4,BLOOD,O
104948,4,Glucose-98,O
104948,4,UreaN-44*,O
104948,4,Creat-1.1,O
104948,4,Na-138,O
104948,4,K-5.3*,O
104948,4,Cl-105,O
104948,4,HCO3-23,O
104948,4,AnGap-15,O
104948,4,[,O
104948,4,**2154-12-14**,O
104948,4,],O
104948,4,04:45PM,O
104948,4,BLOOD,O
104948,4,CK,O
104948,4,(,O
104948,4,CPK,O
104948,4,),O
104948,4,-52,O
104948,4,[,O
104948,4,**2154-12-14**,O
104948,4,],O
104948,4,04:45PM,O
104948,4,BLOOD,O
104948,4,CK-MB-NotDone,O
104948,4,[,O
104948,4,**2154-12-14**,O
104948,4,],O
104948,4,04:45PM,O
104948,4,BLOOD,O
104948,4,Calcium-8.0*,O
104948,4,Phos-3.7,O
104948,4,Mg-2.7*,O
104948,4,UricAcd-3.4,O
104948,4,[,O
104948,4,**2154-12-14**,O
104948,4,],O
104948,4,10:47PM,O
104948,4,BLOOD,O
104948,4,calTIBC-146*,O
104948,4,VitB12-1418*,O
104948,4,Folate-3.5,O
104948,4,Ferritn-1409*,O
104948,4,TRF-112*,O
104948,4,[,O
104948,4,**2154-12-14**,O
104948,4,],O
104948,4,10:47PM,O
104948,4,BLOOD,O
104948,4,TSH-0.69,O
104948,4,[,O
104948,4,**2154-12-15**,O
104948,4,],O
104948,4,06:26AM,O
104948,4,BLOOD,O
104948,4,Cortsol-26.9*,O
104948,4,[,O
104948,4,**2154-12-14**,O
104948,4,],O
104948,4,06:50PM,O
104948,4,BLOOD,O
104948,4,Type-ART,O
104948,4,pO2-60*,O
104948,4,pCO2-50*,O
104948,4,pH-7.30*,O
104948,4,calTCO2-26,O
104948,4,Base,O
104948,4,XS,O
104948,4,--,O
104948,4,1,O
104948,4,Intubat-INTUBATED,O
104948,4,Vent-CONTROLLED,O
104948,4,[,O
104948,4,**2154-12-14**,O
104948,4,],O
104948,4,07:15PM,O
104948,4,BLOOD,O
104948,4,Lactate-2.2*,O
104948,4,[,O
104948,4,**2154-12-15**,O
104948,4,],O
104948,4,12:25AM,O
104948,4,BLOOD,O
104948,4,O2,O
104948,4,Sat-98,O
104948,4,[,O
104948,4,**2154-12-15**,O
104948,4,],O
104948,4,12:25AM,O
104948,4,BLOOD,O
104948,4,freeCa-1.10*,O
104948,4,Brief,O
104948,4,Hospital,O
104948,4,Course,O
104948,4,:,O
104948,4,Note,O
104948,4,:,O
104948,4,the,O
104948,4,majority,O
104948,4,of,O
104948,4,this,O
104948,4,hospital,O
104948,4,course,O
104948,4,refers,O
104948,4,to,O
104948,4,the,O
104948,4,patient,O
104948,4,'s,O
104948,4,ICU,O
104948,4,course,O
104948,4,.,O
104948,4,He,O
104948,4,was,O
104948,4,on,O
104948,4,the,O
104948,4,medical,O
104948,4,floor,O
104948,4,for,O
104948,4,16,O
104948,4,hours,O
104948,4,prior,O
104948,4,to,O
104948,4,discharge,O
104948,4,and,O
104948,4,was,O
104948,4,stable,O
104948,4,during,O
104948,4,this,O
104948,4,time,O
104948,4,.,O
104948,4,.,O
104948,4,#,O
104948,4,Septic,O
104948,4,Shock,O
104948,4,:,O
104948,4,Met,O
104948,4,criteria,O
104948,4,for,O
104948,4,septic,O
104948,4,shock,O
104948,4,.,O
104948,4,On,O
104948,4,presentation,O
104948,4,had,O
104948,4,clear,O
104948,4,pulmonary,O
104948,4,source,O
104948,4,of,O
104948,4,infection,O
104948,4,.,O
104948,4,Initial,O
104948,4,sputums,O
104948,4,grew,O
104948,4,out,O
104948,4,pneumococci,O
104948,4,.,O
104948,4,Patient,O
104948,4,relatively,O
104948,4,immunocompromised,B-ADE
104948,4,due,O
104948,4,both,O
104948,4,to,O
104948,4,cancer,O
104948,4,diagnosis,O
104948,4,and,O
104948,4,chronic,O
104948,4,steroid,B-Drug
104948,4,use,O
104948,4,secondary,O
104948,4,to,O
104948,4,brain,B-Reason
104948,4,tumor,I-Reason
104948,4,.,O
104948,4,On,O
104948,4,admission,O
104948,4,patient,O
104948,4,had,O
104948,4,central,O
104948,4,line,O
104948,4,placed,O
104948,4,",",O
104948,4,CVPs,O
104948,4,maintained,O
104948,4,[,O
104948,4,**7-15**,O
104948,4,],O
104948,4,.,O
104948,4,Patient,O
104948,4,needed,O
104948,4,pressors,B-Drug
104948,4,to,O
104948,4,maintain,B-Reason
104948,4,BP,I-Reason
104948,4,initially,O
104948,4,.,O
104948,4,On,O
104948,4,levophed,B-Drug
104948,4,",",O
104948,4,but,O
104948,4,developed,O
104948,4,some,O
104948,4,tachyarrhythmnias,B-ADE
104948,4,(,I-ADE
104948,4,Afib,I-ADE
104948,4,with,I-ADE
104948,4,RVR,I-ADE
104948,4,),I-ADE
104948,4,so,O
104948,4,was,O
104948,4,switched,O
104948,4,to,O
104948,4,neo,B-Drug
104948,4,.,O
104948,4,Initially,O
104948,4,covered,O
104948,4,with,O
104948,4,Zosyn,B-Drug
104948,4,",",O
104948,4,levoflox,B-Drug
104948,4,and,O
104948,4,vanco,B-Drug
104948,4,.,O
104948,4,Patient,O
104948,4,was,O
104948,4,continued,O
104948,4,on,O
104948,4,atovaquone,B-Drug
104948,4,for,O
104948,4,PCP,B-Reason
104948,4,[,O
104948,4,**Name,O
104948,4,Initial,O
104948,4,(,O
104948,4,PRE,O
104948,4,),O
104948,4,6187**,O
104948,4,],O
104948,4,.,O
104948,4,Patient,O
104948,4,was,O
104948,4,also,O
104948,4,intubated,O
104948,4,on,O
104948,4,presentation,O
104948,4,",",O
104948,4,and,O
104948,4,maintained,O
104948,4,on,O
104948,4,AC,O
104948,4,.,O
104948,4,Patient,O
104948,4,had,O
104948,4,EKGs,O
104948,4,without,O
104948,4,signs,O
104948,4,of,O
104948,4,ischemia,O
104948,4,",",O
104948,4,and,O
104948,4,multiple,O
104948,4,sets,O
104948,4,of,O
104948,4,normal,O
104948,4,cardiac,O
104948,4,enzymes,O
104948,4,.,O
104948,4,Pressors,O
104948,4,were,O
104948,4,largely,O
104948,4,weaned,O
104948,4,by,O
104948,4,HD,O
104948,4,#,O
104948,4,3,O
104948,4,.,O
104948,4,He,O
104948,4,did,O
104948,4,rarely,O
104948,4,require,O
104948,4,brief,O
104948,4,periods,O
104948,4,of,O
104948,4,neosynepherine,B-Drug
104948,4,",",O
104948,4,due,O
104948,4,to,O
104948,4,too-rapid,B-Reason
104948,4,diuresis,I-Reason
104948,4,.,O
104948,4,The,O
104948,4,patient,O
104948,4,had,O
104948,5,a,O
104948,5,normal,O
104948,5,cortisol,O
104948,5,stim,O
104948,5,test,O
104948,5,.,O
104948,5,Historically,O
104948,5,",",O
104948,5,it,O
104948,5,was,O
104948,5,noted,O
104948,5,that,O
104948,5,the,O
104948,5,patient,O
104948,5,had,O
104948,5,a,O
104948,5,red,O
104948,5,left,O
104948,5,knee,O
104948,5,a,O
104948,5,few,O
104948,5,days,O
104948,5,prior,O
104948,5,to,O
104948,5,admission,O
104948,5,.,O
104948,5,This,O
104948,5,knee,O
104948,5,was,O
104948,5,tapped,O
104948,5,by,O
104948,5,ortho,O
104948,5,and,O
104948,5,found,O
104948,5,to,O
104948,5,be,O
104948,5,floridly,O
104948,5,septic,O
104948,5,.,O
104948,5,He,O
104948,5,was,O
104948,5,taken,O
104948,5,to,O
104948,5,the,O
104948,5,OR,O
104948,5,and,O
104948,5,washed,O
104948,5,out,O
104948,5,by,O
104948,5,Ortho,O
104948,5,(,O
104948,5,please,O
104948,5,see,O
104948,5,seperate,O
104948,5,op,O
104948,5,note,O
104948,5,for,O
104948,5,full,O
104948,5,accounting,O
104948,5,of,O
104948,5,this,O
104948,5,procedure,O
104948,5,),O
104948,5,.,O
104948,5,This,O
104948,5,infection,O
104948,5,was,O
104948,5,found,O
104948,5,to,O
104948,5,be,O
104948,5,MSSA,O
104948,5,",",O
104948,5,which,O
104948,5,also,O
104948,5,grew,O
104948,5,out,O
104948,5,of,O
104948,5,his,O
104948,5,blood,O
104948,5,and,O
104948,5,eventually,O
104948,5,out,O
104948,5,of,O
104948,5,his,O
104948,5,R,O
104948,5,chest,O
104948,5,chemo-port,O
104948,5,",",O
104948,5,which,O
104948,5,was,O
104948,5,removed,O
104948,5,by,O
104948,5,surgery,O
104948,5,.,O
104948,5,He,O
104948,5,was,O
104948,5,maintained,O
104948,5,on,O
104948,5,a,O
104948,5,6week,O
104948,5,course,O
104948,5,of,O
104948,5,Nafcillin,B-Drug
104948,5,for,O
104948,5,this,O
104948,5,staph,B-Reason
104948,5,infection,I-Reason
104948,5,.,O
104948,5,A,O
104948,5,TEE,O
104948,5,demonstrated,O
104948,5,no,O
104948,5,signs,O
104948,5,of,O
104948,5,endocarditis,O
104948,5,.,O
104948,5,Infectious,O
104948,5,disease,O
104948,5,was,O
104948,5,consulted,O
104948,5,and,O
104948,5,assisted,O
104948,5,with,O
104948,5,his,O
104948,5,antibiotic,B-Drug
104948,5,regimen,O
104948,5,.,O
104948,5,The,O
104948,5,patient,O
104948,5,completed,O
104948,5,a,O
104948,5,full,O
104948,5,14d,O
104948,5,course,O
104948,5,of,O
104948,5,Levoflox,B-Drug
104948,5,for,O
104948,5,pneumonia,B-Reason
104948,5,.,O
104948,5,The,O
104948,5,patient,O
104948,5,also,O
104948,5,had,O
104948,5,a,O
104948,5,full,O
104948,5,course,O
104948,5,of,O
104948,5,Clinda,B-Drug
104948,5,for,O
104948,5,a,O
104948,5,question,O
104948,5,of,O
104948,5,toxic,B-Reason
104948,5,shock,I-Reason
104948,5,syndrome,I-Reason
104948,5,or,O
104948,5,aspiration,B-Reason
104948,5,pneumonia,I-Reason
104948,5,.,O
104948,5,His,O
104948,5,Vanco,B-Drug
104948,5,was,O
104948,5,d/c,O
104948,5,'d,O
104948,5,after,O
104948,5,5d,O
104948,5,due,O
104948,5,to,O
104948,5,only,O
104948,5,MSSA,O
104948,5,growing,O
104948,5,out,O
104948,5,.,O
104948,5,On,O
104948,5,[,O
104948,5,**12-20**,O
104948,5,],O
104948,5,his,O
104948,5,pre-existing,O
104948,5,R,O
104948,5,chest,O
104948,5,chemo,O
104948,5,port,O
104948,5,was,O
104948,5,noted,O
104948,5,to,O
104948,5,be,O
104948,5,purulent,O
104948,5,and,O
104948,5,was,O
104948,5,removed,O
104948,5,by,O
104948,5,surgery,O
104948,5,.,O
104948,5,This,O
104948,5,grew,O
104948,5,out,O
104948,5,MSSA,O
104948,5,.,O
104948,5,Once,O
104948,5,more,O
104948,5,",",O
104948,5,the,O
104948,5,nafcillin,B-Drug
104948,5,was,O
104948,5,continued,O
104948,5,for,O
104948,5,6week,O
104948,5,total,O
104948,5,course,O
104948,5,.,O
104948,5,A,O
104948,5,[,O
104948,5,**12-21**,O
104948,5,],O
104948,5,culture,O
104948,5,grew,O
104948,5,out,O
104948,5,yeast,B-Reason
104948,5,and,O
104948,5,he,O
104948,5,was,O
104948,5,started,O
104948,5,on,O
104948,5,a,O
104948,5,course,O
104948,5,of,O
104948,5,fluconisol,B-Drug
104948,5,as,O
104948,5,per,O
104948,5,ID,O
104948,5,.,O
104948,5,He,O
104948,5,recieved,O
104948,5,a,O
104948,5,full,O
104948,5,Ophtho,O
104948,5,eval,O
104948,5,which,O
104948,5,demonstrated,O
104948,5,no,O
104948,5,ocular,O
104948,5,involvment,O
104948,5,.,O
104948,5,Planned,O
104948,5,course,O
104948,5,of,O
104948,5,treatment,O
104948,5,is,O
104948,5,for,O
104948,5,nafcillin,B-Drug
104948,5,for,O
104948,5,total,O
104948,5,of,O
104948,5,6,O
104948,5,weeks,O
104948,5,to,O
104948,5,end,O
104948,5,[,O
104948,5,**1-30**,O
104948,5,],O
104948,5,",",O
104948,5,fluconazole,B-Drug
104948,5,for,O
104948,5,2,O
104948,5,weeks,O
104948,5,total,O
104948,5,to,O
104948,5,end,O
104948,5,[,O
104948,5,**1-9**,O
104948,5,],O
104948,5,",",O
104948,5,and,O
104948,5,ceftriaxone,B-Drug
104948,5,to,O
104948,5,end,O
104948,5,[,O
104948,5,**1-10**,O
104948,5,],O
104948,5,.,O
104948,5,.,O
104948,5,#,O
104948,5,Afib,B-Reason
104948,5,c,I-Reason
104948,5,RvR,I-Reason
104948,5,:,O
104948,5,New-onset,O
104948,5,afib,O
104948,5,in,O
104948,5,the,O
104948,5,face,O
104948,5,of,O
104948,5,sepsis,B-Reason
104948,5,",",O
104948,5,hypotension,B-Reason
104948,5,",",O
104948,5,infection,B-Reason
104948,5,.,O
104948,5,Patient,O
104948,6,initially,O
104948,6,controlled,O
104948,6,with,O
104948,6,boluses,O
104948,6,of,O
104948,6,Diltiazem,B-Drug
104948,6,or,O
104948,6,Lopressor,B-Drug
104948,6,.,O
104948,6,Often,O
104948,6,returned,O
104948,6,into,O
104948,6,Afib,B-Reason
104948,6,during,O
104948,6,times,O
104948,6,of,O
104948,6,increased,O
104948,6,activity,O
104948,6,or,O
104948,6,stress,O
104948,6,.,O
104948,6,Used,O
104948,6,neosynepharine,B-Drug
104948,6,which,O
104948,6,seemed,O
104948,6,less,O
104948,6,arrhythmagenic,O
104948,6,.,O
104948,6,Amiodarone,B-Drug
104948,6,was,O
104948,6,tried,O
104948,6,initially,O
104948,6,for,O
104948,6,control,B-Reason
104948,6,",",O
104948,6,but,O
104948,6,the,O
104948,6,patient,O
104948,6,became,O
104948,6,to,O
104948,6,bradycardic,B-ADE
104948,6,on,O
104948,6,this,O
104948,6,[,O
104948,6,**Doctor,O
104948,6,Last,O
104948,6,Name,O
104948,6,360**,O
104948,6,],O
104948,6,.,O
104948,6,As,O
104948,6,patient,O
104948,6,was,O
104948,6,weaned,O
104948,6,from,O
104948,6,pressors,B-Drug
104948,6,he,O
104948,6,was,O
104948,6,begun,O
104948,6,on,O
104948,6,a,O
104948,6,regimen,O
104948,6,of,O
104948,6,metoprolol,B-Drug
104948,6,which,O
104948,6,seemed,O
104948,6,to,O
104948,6,control,B-Reason
104948,6,his,I-Reason
104948,6,rate,I-Reason
104948,6,well,O
104948,6,.,O
104948,6,He,O
104948,6,did,O
104948,6,ocassionally,O
104948,6,return,O
104948,6,to,O
104948,6,RVR,B-Reason
104948,6,",",O
104948,6,which,O
104948,6,was,O
104948,6,treated,O
104948,6,with,O
104948,6,boluses,O
104948,6,of,O
104948,6,dilt,B-Drug
104948,6,or,O
104948,6,lopressor,B-Drug
104948,6,with,O
104948,6,good,O
104948,6,effect,O
104948,6,.,O
104948,6,He,O
104948,6,was,O
104948,6,then,O
104948,6,restarted,O
104948,6,on,O
104948,6,amiodarone,B-Drug
104948,6,[,O
104948,6,**1-1**,O
104948,6,],O
104948,6,and,O
104948,6,responded,O
104948,6,to,O
104948,6,it,O
104948,6,well,O
104948,6,.,O
104948,6,Due,O
104948,6,to,O
104948,6,his,O
104948,6,brain,O
104948,6,tumor,O
104948,6,he,O
104948,6,was,O
104948,6,note,O
104948,6,anticoagulated,O
104948,6,during,O
104948,6,his,O
104948,6,time,O
104948,6,in,O
104948,6,the,O
104948,6,ICU,O
104948,6,.,O
104948,6,The,O
104948,6,risks,O
104948,6,and,O
104948,6,benefits,O
104948,6,were,O
104948,6,discussed,O
104948,6,.,O
104948,6,It,O
104948,6,was,O
104948,6,felt,O
104948,6,that,O
104948,6,the,O
104948,6,risks,O
104948,6,of,O
104948,6,ICH,O
104948,6,outweighed,O
104948,6,the,O
104948,6,benefits,O
104948,6,of,O
104948,6,stroke,O
104948,6,prevention,O
104948,6,at,O
104948,6,this,O
104948,6,time,O
104948,6,.,O
104948,6,Plans,O
104948,6,were,O
104948,6,made,O
104948,6,to,O
104948,6,readdress,O
104948,6,this,O
104948,6,issue,O
104948,6,once,O
104948,6,the,O
104948,6,patient,O
104948,6,'s,O
104948,6,mental,O
104948,6,status,O
104948,6,improved,O
104948,6,.,O
104948,6,.,O
104948,6,#,O
104948,6,Septic,B-Reason
104948,6,Arthritis,I-Reason
104948,6,:,O
104948,6,As,O
104948,6,above,O
104948,6,",",O
104948,6,had,O
104948,6,septic,O
104948,6,arthritis,O
104948,6,of,O
104948,6,L,O
104948,6,knee,O
104948,6,treated,O
104948,6,via,O
104948,6,washout,O
104948,6,by,O
104948,6,ortho,O
104948,6,on,O
104948,6,[,O
104948,6,**12-17**,O
104948,6,],O
104948,6,.,O
104948,6,Nafcillin,B-Drug
104948,6,x6weeks,O
104948,6,per,O
104948,6,ID,O
104948,6,started,O
104948,6,on,O
104948,6,[,O
104948,6,**12-19**,O
104948,6,],O
104948,6,.,O
104948,6,Nafcillin,B-Drug
104948,6,is,O
104948,6,scheduled,O
104948,6,to,O
104948,6,finish,O
104948,6,on,O
104948,6,[,O
104948,6,**1-30**,O
104948,6,],O
104948,6,.,O
104948,6,Patient,O
104948,6,did,O
104948,6,have,O
104948,6,a,O
104948,6,swollen,O
104948,6,L,O
104948,6,wrist,O
104948,6,later,O
104948,6,in,O
104948,6,his,O
104948,6,course,O
104948,6,",",O
104948,6,but,O
104948,6,this,O
104948,6,was,O
104948,6,tapped,O
104948,6,by,O
104948,6,Ortho,O
104948,6,and,O
104948,6,never,O
104948,6,grew,O
104948,6,out,O
104948,6,any,O
104948,6,bacteria,O
104948,6,.,O
104948,6,Plastics-hand,O
104948,6,was,O
104948,6,consulted,O
104948,6,and,O
104948,6,felt,O
104948,6,clinically,O
104948,6,that,O
104948,6,this,O
104948,6,was,O
104948,6,not,O
104948,6,a,O
104948,6,septic,O
104948,6,joint,O
104948,6,",",O
104948,6,instead,O
104948,6,just,O
104948,6,a,O
104948,6,manifestation,O
104948,6,of,O
104948,6,his,O
104948,6,chronic,O
104948,6,RA,O
104948,6,.,O
104948,6,Ortho,O
104948,6,also,O
104948,6,felt,O
104948,6,it,O
104948,6,was,O
104948,6,not,O
104948,6,prudent,O
104948,6,to,O
104948,6,washout,O
104948,6,his,O
104948,6,R,O
104948,6,knee,O
104948,6,",",O
104948,6,which,O
104948,6,was,O
104948,6,clinically,O
104948,6,asymptomatic,O
104948,6,during,O
104948,6,his,O
104948,6,ICU,O
104948,6,course,O
104948,6,.,O
104948,6,His,O
104948,6,L,O
104948,6,knee,O
104948,6,healed,O
104948,6,well,O
104948,6,and,O
104948,6,the,O
104948,6,staples,O
104948,6,and,O
104948,6,drain,O
104948,6,were,O
104948,6,removed,O
104948,6,without,O
104948,6,incidence,O
104948,6,.,O
104948,6,He,O
104948,6,has,O
104948,6,been,O
104948,6,signed,O
104948,6,off,O
104948,6,from,O
104948,6,direct,O
104948,6,ortho,O
104948,7,care,O
104948,7,",",O
104948,7,and,O
104948,7,is,O
104948,7,weight-bearing,O
104948,7,as,O
104948,7,tolerated,O
104948,7,at,O
104948,7,time,O
104948,7,of,O
104948,7,ICU,O
104948,7,discharge,O
104948,7,.,O
104948,7,.,O
104948,7,#,O
104948,7,Respiratory,O
104948,7,status,O
104948,7,:,O
104948,7,Patient,O
104948,7,was,O
104948,7,maintained,O
104948,7,on,O
104948,7,ARDS-style,O
104948,7,ventilation,O
104948,7,while,O
104948,7,on,O
104948,7,the,O
104948,7,ventilator,O
104948,7,.,O
104948,7,He,O
104948,7,has,O
104948,7,a,O
104948,7,bronchoscopy,O
104948,7,on,O
104948,7,[,O
104948,7,**12-18**,O
104948,7,],O
104948,7,which,O
104948,7,showed,O
104948,7,diffuse,O
104948,7,thick,O
104948,7,bloody,O
104948,7,sputum,O
104948,7,greatest,O
104948,7,in,O
104948,7,the,O
104948,7,R,O
104948,7,LL,O
104948,7,.,O
104948,7,By,O
104948,7,[,O
104948,7,**12-19**,O
104948,7,],O
104948,7,the,O
104948,7,patient,O
104948,7,was,O
104948,7,changed,O
104948,7,to,O
104948,7,pressure,O
104948,7,support,O
104948,7,ventilation,O
104948,7,.,O
104948,7,The,O
104948,7,patient,O
104948,7,was,O
104948,7,activily,O
104948,7,diuresed,O
104948,7,at,O
104948,7,this,O
104948,7,time,O
104948,7,",",O
104948,7,with,O
104948,7,good,O
104948,7,effect,O
104948,7,and,O
104948,7,improving,O
104948,7,respiratory,O
104948,7,status,O
104948,7,.,O
104948,7,The,O
104948,7,patient,O
104948,7,tested,O
104948,7,negative,O
104948,7,for,O
104948,7,legionella,O
104948,7,and,O
104948,7,influenza,O
104948,7,.,O
104948,7,The,O
104948,7,patient,O
104948,7,was,O
104948,7,quickly,O
104948,7,weaned,O
104948,7,to,O
104948,7,CPAP+PS,O
104948,7,of,O
104948,7,[,O
104948,7,**4-7**,O
104948,7,],O
104948,7,",",O
104948,7,but,O
104948,7,was,O
104948,7,difficult,O
104948,7,to,O
104948,7,wean,O
104948,7,fully,O
104948,7,from,O
104948,7,the,O
104948,7,vent,O
104948,7,due,O
104948,7,mainly,O
104948,7,to,O
104948,7,his,O
104948,7,mental,O
104948,7,status,O
104948,7,.,O
104948,7,He,O
104948,7,was,O
104948,7,extubated,O
104948,7,on,O
104948,7,[,O
104948,7,**12-24**,O
104948,7,],O
104948,7,with,O
104948,7,great,O
104948,7,success,O
104948,7,.,O
104948,7,On,O
104948,7,[,O
104948,7,**12-25**,O
104948,7,],O
104948,7,the,O
104948,7,patient,O
104948,7,was,O
104948,7,noted,O
104948,7,to,O
104948,7,have,O
104948,7,an,O
104948,7,increasing,O
104948,7,o2,O
104948,7,requirement,O
104948,7,and,O
104948,7,a,O
104948,7,CXR,O
104948,7,demonstrated,O
104948,7,a,O
104948,7,moderate-sized,O
104948,7,R,O
104948,7,pneumothorax,O
104948,7,.,O
104948,7,Thoracic,O
104948,7,surgery,O
104948,7,was,O
104948,7,consulted,O
104948,7,and,O
104948,7,placed,O
104948,7,a,O
104948,7,chest,O
104948,7,tube,O
104948,7,.,O
104948,7,This,O
104948,7,tube,O
104948,7,was,O
104948,7,intermittantly,O
104948,7,to,O
104948,7,wall-suction,O
104948,7,",",O
104948,7,water-seal,O
104948,7,or,O
104948,7,clamped,O
104948,7,.,O
104948,7,On,O
104948,7,[,O
104948,7,**1-2**,O
104948,7,],O
104948,7,it,O
104948,7,was,O
104948,7,d/c,O
104948,7,'d,O
104948,7,",",O
104948,7,with,O
104948,7,the,O
104948,7,pneumothoax,O
104948,7,smaller,O
104948,7,in,O
104948,7,size,O
104948,7,.,O
104948,7,.,O
104948,7,#,O
104948,7,GBM,O
104948,7,:,O
104948,7,Head,O
104948,7,CTs,O
104948,7,compared,O
104948,7,to,O
104948,7,his,O
104948,7,baseline,O
104948,7,[,O
104948,7,**Hospital1,O
104948,7,2025**,O
104948,7,],O
104948,7,scans,O
104948,7,showed,O
104948,7,no,O
104948,7,interval,O
104948,7,change,O
104948,7,.,O
104948,7,He,O
104948,7,was,O
104948,7,maintained,O
104948,7,on,O
104948,7,his,O
104948,7,baseline,O
104948,7,3mg,O
104948,7,of,O
104948,7,Dexamethasone,B-Drug
104948,7,while,O
104948,7,inpatient,O
104948,7,here,O
104948,7,.,O
104948,7,It,O
104948,7,appears,O
104948,7,that,O
104948,7,neurooncs,O
104948,7,original,O
104948,7,plans,O
104948,7,were,O
104948,7,to,O
104948,7,taper,O
104948,7,the,O
104948,7,dexamethasone,B-Drug
104948,7,.,O
104948,7,We,O
104948,7,were,O
104948,7,unable,O
104948,7,to,O
104948,7,contact,O
104948,7,primary,O
104948,7,neuro-oncoligist,O
104948,7,to,O
104948,7,discuss,O
104948,7,steroid,B-Drug
104948,7,taper,O
104948,7,but,O
104948,7,this,O
104948,7,should,O
104948,7,be,O
104948,7,discussed,O
104948,7,with,O
104948,7,Dr.,O
104948,7,[,O
104948,7,**Last,O
104948,7,Name,O
104948,7,(,O
104948,7,STitle,O
104948,7,),O
104948,7,**,O
104948,7,],O
104948,7,when,O
104948,7,he,O
104948,7,becomes,O
104948,7,available,O
104948,7,.,O
104948,7,.,O
104948,7,#,O
104948,7,Anemia/thrombocytopenia,O
104948,7,:,O
104948,7,Had,O
104948,7,anemia,O
104948,7,of,O
104948,7,chronic,O
104948,7,disease,O
104948,7,",",O
104948,7,admitted,O
104948,7,with,O
104948,7,thrombocytopenia,B-ADE
104948,7,attributed,O
104948,7,to,O
104948,7,Avastin,B-Drug
104948,7,and,O
104948,7,timador,B-Drug
104948,7,.,O
104948,7,His,O
104948,7,thrombocytopenia,O
104948,7,was,O
104948,7,asymptomatic,O
104948,7,during,O
104948,7,his,O
104948,7,hospital,O
104948,7,course,O
104948,7,",",O
104948,7,and,O
104948,7,steadily,O
104948,7,improved,O
104948,7,.,O
104948,7,His,O
104948,7,anemia,O
104948,7,was,O
104948,7,mild,O
104948,7,",",O
104948,8,and,O
104948,8,did,O
104948,8,require,O
104948,8,occasional,O
104948,8,transfusion,O
104948,8,.,O
104948,8,.,O
104948,8,#,O
104948,8,Hyperglycemia,B-Reason
104948,8,:,O
104948,8,Intitally,O
104948,8,hyperglycemic,O
104948,8,in,O
104948,8,face,O
104948,8,of,O
104948,8,sepsis,O
104948,8,",",O
104948,8,controlled,O
104948,8,with,O
104948,8,SS,O
104948,8,insulin,B-Drug
104948,8,and,O
104948,8,resolved,O
104948,8,on,O
104948,8,its,O
104948,8,own,O
104948,8,.,O
104948,8,.,O
104948,8,#,O
104948,8,R,O
104948,8,Chest,B-Reason
104948,8,wound,I-Reason
104948,8,:,O
104948,8,Co,O
104948,8,n't,O
104948,8,to,O
104948,8,drain,O
104948,8,purulent,O
104948,8,material,O
104948,8,s/p,O
104948,8,removal,O
104948,8,of,O
104948,8,port,O
104948,8,.,O
104948,8,Surgery,O
104948,8,recommended,O
104948,8,QID,O
104948,8,dilute,O
104948,8,(,O
104948,8,[,O
104948,8,**12-6**,O
104948,8,],O
104948,8,),O
104948,8,Dakin,B-Drug
104948,8,'s,I-Drug
104948,8,solution,I-Drug
104948,8,and,O
104948,8,close,O
104948,8,f/u,O
104948,8,.,O
104948,8,Any,O
104948,8,fluctuant,O
104948,8,areas,O
104948,8,must,O
104948,8,be,O
104948,8,debrided,O
104948,8,.,O
104948,8,.,O
104948,8,#,O
104948,8,Mental,O
104948,8,Status,O
104948,8,:,O
104948,8,The,O
104948,8,patient,O
104948,8,presented,O
104948,8,with,O
104948,8,altered,O
104948,8,mental,O
104948,8,status,O
104948,8,felt,O
104948,8,to,O
104948,8,be,O
104948,8,due,O
104948,8,to,O
104948,8,sepsis,O
104948,8,.,O
104948,8,He,O
104948,8,did,O
104948,8,take,O
104948,8,some,O
104948,8,days,O
104948,8,to,O
104948,8,awaken,O
104948,8,from,O
104948,8,his,O
104948,8,intubated,O
104948,8,and,O
104948,8,sedated,O
104948,8,state,O
104948,8,.,O
104948,8,He,O
104948,8,continued,O
104948,8,to,O
104948,8,be,O
104948,8,Aox1-2,O
104948,8,in,O
104948,8,the,O
104948,8,MICU,O
104948,8,",",O
104948,8,with,O
104948,8,symptoms,O
104948,8,consistent,O
104948,8,with,O
104948,8,delerium,O
104948,8,.,O
104948,8,A,O
104948,8,repeat,O
104948,8,head,O
104948,8,CT,O
104948,8,showed,O
104948,8,no,O
104948,8,change,O
104948,8,;,O
104948,8,his,O
104948,8,delerium,O
104948,8,was,O
104948,8,felt,O
104948,8,to,O
104948,8,be,O
104948,8,mainly,O
104948,8,post-septic,O
104948,8,and,O
104948,8,ICU,O
104948,8,related,O
104948,8,and,O
104948,8,appeared,O
104948,8,to,O
104948,8,be,O
104948,8,slowly,O
104948,8,intervally,O
104948,8,improving,O
104948,8,each,O
104948,8,day,O
104948,8,.,O
104948,8,.,O
104948,8,#,O
104948,8,Prophylaxis,B-Reason
104948,8,:,O
104948,8,Patient,O
104948,8,was,O
104948,8,initially,O
104948,8,on,O
104948,8,pneumoboots,O
104948,8,and,O
104948,8,then,O
104948,8,Heparin,B-Drug
104948,8,SC,O
104948,8,",",O
104948,8,a,O
104948,8,bowel,O
104948,8,regmimen,O
104948,8,and,O
104948,8,a,O
104948,8,Gi,O
104948,8,prophlyaxsis,O
104948,8,throughout,O
104948,8,his,O
104948,8,hospital,O
104948,8,course,O
104948,8,.,O
104948,8,.,O
104948,8,#,O
104948,8,Electrolytes,O
104948,8,:,O
104948,8,The,O
104948,8,patient,O
104948,8,required,O
104948,8,extensive,O
104948,8,repletion,O
104948,8,of,O
104948,8,his,O
104948,8,potassium,O
104948,8,during,O
104948,8,his,O
104948,8,ICU,O
104948,8,course,O
104948,8,",",O
104948,8,often,O
104948,8,requiring,O
104948,8,q6hr,O
104948,8,lyte,O
104948,8,checks,O
104948,8,and,O
104948,8,100-200meq,O
104948,8,of,O
104948,8,K+,O
104948,8,per,O
104948,8,day,O
104948,8,.,O
104948,8,This,O
104948,8,was,O
104948,8,felt,O
104948,8,to,O
104948,8,be,O
104948,8,mostly,O
104948,8,due,O
104948,8,to,O
104948,8,a,O
104948,8,diarrhea,O
104948,8,and,O
104948,8,thus,O
104948,8,GI,O
104948,8,loss,O
104948,8,",",O
104948,8,and,O
104948,8,was,O
104948,8,resolving,O
104948,8,at,O
104948,8,the,O
104948,8,end,O
104948,8,of,O
104948,8,his,O
104948,8,hospital,O
104948,8,course,O
104948,8,as,O
104948,8,diarrhea,O
104948,8,resolved,O
104948,8,.,O
104948,8,.,O
104948,8,#,O
104948,8,Nutrition,O
104948,8,:,O
104948,8,The,O
104948,8,patient,O
104948,8,was,O
104948,8,maintained,O
104948,8,on,O
104948,8,TF,O
104948,8,while,O
104948,8,intubated,O
104948,8,",",O
104948,8,and,O
104948,8,also,O
104948,8,s/p,O
104948,8,intubation,O
104948,8,as,O
104948,8,he,O
104948,8,failed,O
104948,8,his,O
104948,8,initial,O
104948,8,speech,O
104948,8,and,O
104948,8,swallow,O
104948,8,exams,O
104948,8,.,O
104948,8,On,O
104948,8,[,O
104948,8,**1-3**,O
104948,8,],O
104948,8,he,O
104948,8,passed,O
104948,8,his,O
104948,8,speech,O
104948,8,and,O
104948,8,swallow,O
104948,8,bedside,O
104948,8,test,O
104948,8,.,O
104948,8,.,O
104948,8,#,O
104948,8,LFTs,O
104948,8,:,O
104948,8,Patient,O
104948,8,had,O
104948,8,elevated,O
104948,8,LFTs,O
104948,8,on,O
104948,8,presentation,O
104948,8,which,O
104948,8,were,O
104948,8,attributed,O
104948,8,to,O
104948,8,sepsis,O
104948,8,.,O
104948,8,This,O
104948,8,abnormality,O
104948,8,resolved,O
104948,8,as,O
104948,8,the,O
104948,8,patient,O
104948,8,'s,O
104948,8,clinical,O
104948,8,picture,O
104948,8,improved,O
104948,8,.,O
104948,8,He,O
104948,8,should,O
104948,8,continue,O
104948,8,on,O
104948,8,weekly,O
104948,9,LFT,O
104948,9,checks,O
104948,9,due,O
104948,9,to,O
104948,9,his,O
104948,9,continuing,O
104948,9,nafcillin,B-Drug
104948,9,.,O
104948,9,.,O
104948,9,#,O
104948,9,PT/OT,O
104948,9,:,O
104948,9,after,O
104948,9,extubation,O
104948,9,the,O
104948,9,patient,O
104948,9,was,O
104948,9,followed,O
104948,9,actively,O
104948,9,by,O
104948,9,PT,O
104948,9,and,O
104948,9,OT,O
104948,9,.,O
104948,9,Medications,O
104948,9,on,O
104948,9,Admission,O
104948,9,:,O
104948,9,#,O
104948,9,Naproxen,B-Drug
104948,9,prn,O
104948,9,#,O
104948,9,Mepron,B-Drug
104948,9,(,O
104948,9,prophylaxis,B-Reason
104948,9,),O
104948,9,#,O
104948,9,Hydrocodone,B-Drug
104948,9,#,O
104948,9,Dexamethasone,B-Drug
104948,9,3mg,O
104948,9,#,O
104948,9,Avastin,B-Drug
104948,9,(,O
104948,9,last,O
104948,9,received,O
104948,9,2wks,O
104948,9,ago,O
104948,9,",",O
104948,9,due,O
104948,9,on,O
104948,9,Monday,O
104948,9,[,O
104948,9,**2154-12-16**,O
104948,9,],O
104948,9,),O
104948,9,#,O
104948,9,Lipid,O
104948,9,lowering,O
104948,9,[,O
104948,9,**Doctor,O
104948,9,Last,O
104948,9,Name,O
104948,9,360**,O
104948,9,],O
104948,9,(,O
104948,9,wife,O
104948,9,unsure,O
104948,9,of,O
104948,9,name,O
104948,9,),O
104948,9,#,O
104948,9,Timador,B-Drug
104948,9,(,O
104948,9,was,O
104948,9,previously,O
104948,9,on,O
104948,9,this,O
104948,9,",",O
104948,9,but,O
104948,9,was,O
104948,9,stopped,O
104948,9,[,O
104948,9,**1-4**,O
104948,9,],O
104948,9,to,O
104948,9,thrombocytopenia,B-ADE
104948,9,),O
104948,9,Discharge,O
104948,9,Medications,O
104948,9,:,O
104948,9,1,O
104948,9,.,O
104948,9,Heparin,B-Drug
104948,9,(,I-Drug
104948,9,Porcine,I-Drug
104948,9,),I-Drug
104948,9,"5,000",O
104948,9,unit/mL,O
104948,9,Solution,O
104948,9,Sig,O
104948,9,:,O
104948,9,5000,O
104948,9,(,O
104948,9,5000,O
104948,9,),O
104948,9,units,O
104948,9,Injection,O
104948,9,TID,O
104948,9,(,O
104948,9,3,O
104948,9,times,O
104948,9,a,O
104948,9,day,O
104948,9,),O
104948,9,.,O
104948,9,2,O
104948,9,.,O
104948,9,Senna,B-Drug
104948,9,8.6,O
104948,9,mg,O
104948,9,Tablet,O
104948,9,Sig,O
104948,9,:,O
104948,9,One,O
104948,9,(,O
104948,9,1,O
104948,9,),O
104948,9,Tablet,O
104948,9,PO,O
104948,9,BID,O
104948,9,(,O
104948,9,2,O
104948,9,times,O
104948,9,a,O
104948,9,day,O
104948,9,),O
104948,9,as,O
104948,9,needed,O
104948,9,.,O
104948,9,3,O
104948,9,.,O
104948,9,Docusate,B-Drug
104948,9,Sodium,I-Drug
104948,9,50,O
104948,9,mg/5,O
104948,9,mL,O
104948,9,Liquid,O
104948,9,Sig,O
104948,9,:,O
104948,9,Five,O
104948,9,(,O
104948,9,5,O
104948,9,),O
104948,9,ml,O
104948,9,PO,O
104948,9,BID,O
104948,9,(,O
104948,9,2,O
104948,9,times,O
104948,9,a,O
104948,9,day,O
104948,9,),O
104948,9,.,O
104948,9,4,O
104948,9,.,O
104948,9,Atovaquone,B-Drug
104948,9,750,O
104948,9,mg/5,O
104948,9,mL,O
104948,9,Suspension,O
104948,9,Sig,O
104948,9,:,O
104948,9,Seven,O
104948,9,[,O
104948,9,**Age,O
104948,9,over,O
104948,9,90,O
104948,9,1230**,O
104948,9,],O
104948,9,y,O
104948,9,(,O
104948,9,750,O
104948,9,),O
104948,9,mg,O
104948,9,PO,O
104948,9,BID,O
104948,9,(,O
104948,9,2,O
104948,9,times,O
104948,9,a,O
104948,9,day,O
104948,9,),O
104948,9,.,O
104948,9,5,O
104948,9,.,O
104948,9,Nystatin,B-Drug
104948,9,"100,000",O
104948,9,unit/mL,O
104948,9,Suspension,O
104948,9,Sig,O
104948,9,:,O
104948,9,Five,O
104948,9,(,O
104948,9,5,O
104948,9,),O
104948,9,ML,O
104948,9,PO,O
104948,9,QID,O
104948,9,(,O
104948,9,4,O
104948,9,times,O
104948,9,a,O
104948,9,day,O
104948,9,),O
104948,9,as,O
104948,9,needed,O
104948,9,.,O
104948,9,6,O
104948,9,.,O
104948,9,Dexamethasone,B-Drug
104948,9,1.5,O
104948,9,mg,O
104948,9,Tablet,O
104948,9,Sig,O
104948,9,:,O
104948,9,Two,O
104948,9,(,O
104948,9,2,O
104948,9,),O
104948,9,Tablet,O
104948,9,PO,O
104948,9,DAILY,O
104948,9,(,O
104948,9,Daily,O
104948,9,),O
104948,9,.,O
104948,9,7,O
104948,9,.,O
104948,9,Acetaminophen,B-Drug
104948,9,325,O
104948,9,mg,O
104948,9,Tablet,O
104948,9,Sig,O
104948,9,:,O
104948,9,1-2,O
104948,9,Tablets,O
104948,9,PO,O
104948,9,Q6H,O
104948,9,(,O
104948,9,every,O
104948,9,6,O
104948,9,hours,O
104948,9,),O
104948,9,as,O
104948,9,needed,O
104948,9,.,O
104948,9,8,O
104948,9,.,O
104948,9,Guaifenesin,B-Drug
104948,9,100,O
104948,9,mg/5,O
104948,9,mL,O
104948,9,Syrup,O
104948,9,Sig,O
104948,9,:,O
104948,9,Fifteen,O
104948,9,(,O
104948,9,15,O
104948,9,),O
104948,9,ML,O
104948,9,PO,O
104948,9,Q6H,O
104948,9,(,O
104948,9,every,O
104948,9,6,O
104948,9,hours,O
104948,9,),O
104948,9,as,O
104948,9,needed,O
104948,9,for,O
104948,9,cough,B-Reason
104948,9,.,O
104948,9,9,O
104948,9,.,O
104948,9,Fluconazole,B-Drug
104948,9,200,O
104948,9,mg,O
104948,9,Tablet,O
104948,9,Sig,O
104948,9,:,O
104948,9,Two,O
104948,9,(,O
104948,9,2,O
104948,9,),O
104948,9,Tablet,O
104948,9,PO,O
104948,9,Q24H,O
104948,9,(,O
104948,9,every,O
104948,10,24,O
104948,10,hours,O
104948,10,),O
104948,10,for,O
104948,10,2,O
104948,10,weeks,O
104948,10,:,O
104948,10,last,O
104948,10,day,O
104948,10,[,O
104948,10,**1-9**,O
104948,10,],O
104948,10,.,O
104948,10,10,O
104948,10,.,O
104948,10,Metoprolol,B-Drug
104948,10,Tartrate,I-Drug
104948,10,25,O
104948,10,mg,O
104948,10,Tablet,O
104948,10,Sig,O
104948,10,:,O
104948,10,0.5,O
104948,10,Tablet,O
104948,10,PO,O
104948,10,TID,O
104948,10,(,O
104948,10,3,O
104948,10,times,O
104948,10,a,O
104948,10,day,O
104948,10,),O
104948,10,:,O
104948,10,hold,O
104948,10,for,O
104948,10,HR,O
104948,10,<,O
104948,10,50,O
104948,10,and,O
104948,10,SBP,O
104948,10,<,O
104948,10,100,O
104948,10,.,O
104948,10,11,O
104948,10,.,O
104948,10,Amiodarone,B-Drug
104948,10,200,O
104948,10,mg,O
104948,10,Tablet,O
104948,10,Sig,O
104948,10,:,O
104948,10,Two,O
104948,10,(,O
104948,10,2,O
104948,10,),O
104948,10,Tablet,O
104948,10,PO,O
104948,10,BID,O
104948,10,(,O
104948,10,2,O
104948,10,times,O
104948,10,a,O
104948,10,day,O
104948,10,),O
104948,10,:,O
104948,10,[,O
104948,10,**Hospital1,O
104948,10,**,O
104948,10,],O
104948,10,until,O
104948,10,[,O
104948,10,**1-7**,O
104948,10,],O
104948,10,then,O
104948,10,400mg,O
104948,10,daily,O
104948,10,.,O
104948,10,12,O
104948,10,.,O
104948,10,Famotidine,B-Drug
104948,10,10,O
104948,10,mg/mL,O
104948,10,Solution,O
104948,10,Sig,O
104948,10,:,O
104948,10,Twenty,O
104948,10,(,O
104948,10,20,O
104948,10,),O
104948,10,mg,O
104948,10,Intravenous,O
104948,10,Q12H,O
104948,10,(,O
104948,10,every,O
104948,10,12,O
104948,10,hours,O
104948,10,),O
104948,10,.,O
104948,10,13,O
104948,10,.,O
104948,10,Ceftriaxone-Dextrose,B-Drug
104948,10,(,I-Drug
104948,10,Iso-osm,I-Drug
104948,10,),I-Drug
104948,10,1,O
104948,10,gram/50,O
104948,10,mL,O
104948,10,Piggyback,O
104948,10,Sig,O
104948,10,:,O
104948,10,One,O
104948,10,(,O
104948,10,1,O
104948,10,),O
104948,10,gram,O
104948,10,Intravenous,O
104948,10,Q24H,O
104948,10,(,O
104948,10,every,O
104948,10,24,O
104948,10,hours,O
104948,10,),O
104948,10,.,O
104948,10,14,O
104948,10,.,O
104948,10,Nafcillin,B-Drug
104948,10,in,I-Drug
104948,10,D2.4W,I-Drug
104948,10,2,O
104948,10,gram/100,O
104948,10,mL,O
104948,10,Piggyback,O
104948,10,Sig,O
104948,10,:,O
104948,10,Two,O
104948,10,(,O
104948,10,2,O
104948,10,),O
104948,10,grams,O
104948,10,Intravenous,O
104948,10,Q6H,O
104948,10,(,O
104948,10,every,O
104948,10,6,O
104948,10,hours,O
104948,10,),O
104948,10,for,O
104948,10,6,O
104948,10,weeks,O
104948,10,:,O
104948,10,last,O
104948,10,day,O
104948,10,[,O
104948,10,**1-30**,O
104948,10,],O
104948,10,.,O
104948,10,15,O
104948,10,.,O
104948,10,Heparin,B-Drug
104948,10,Lock,I-Drug
104948,10,Flush,I-Drug
104948,10,(,I-Drug
104948,10,Porcine,I-Drug
104948,10,),I-Drug
104948,10,100,O
104948,10,unit/mL,O
104948,10,Syringe,O
104948,10,Sig,O
104948,10,:,O
104948,10,Two,O
104948,10,(,O
104948,10,2,O
104948,10,),O
104948,10,ML,O
104948,10,Intravenous,O
104948,10,DAILY,O
104948,10,(,O
104948,10,Daily,O
104948,10,),O
104948,10,as,O
104948,10,needed,O
104948,10,.,O
104948,10,16,O
104948,10,.,O
104948,10,Insulin,B-Drug
104948,10,NPH,I-Drug
104948,10,Human,I-Drug
104948,10,Recomb,I-Drug
104948,10,100,O
104948,10,unit/mL,O
104948,10,Cartridge,O
104948,10,Sig,O
104948,10,:,O
104948,10,Five,O
104948,10,(,O
104948,10,5,O
104948,10,),O
104948,10,units,O
104948,10,Subcutaneous,O
104948,10,twice,O
104948,10,a,O
104948,10,day,O
104948,10,.,O
104948,10,17,O
104948,10,.,O
104948,10,Insulin,B-Drug
104948,10,Regular,I-Drug
104948,10,Human,I-Drug
104948,10,300,O
104948,10,unit/3,O
104948,10,mL,O
104948,10,Insulin,B-Drug
104948,10,Pen,O
104948,10,Sig,O
104948,10,:,O
104948,10,sliding,O
104948,10,scale,O
104948,10,Subcutaneous,O
104948,10,four,O
104948,10,times,O
104948,10,a,O
104948,10,day,O
104948,10,:,O
104948,10,sliding,O
104948,10,scale,O
104948,10,.,O
104948,10,Discharge,O
104948,10,Disposition,O
104948,10,:,O
104948,10,Extended,O
104948,10,Care,O
104948,10,Facility,O
104948,10,:,O
104948,10,[,O
104948,10,**Hospital3,O
104948,10,7**,O
104948,10,],O
104948,10,&,O
104948,10,Rehab,O
104948,10,Center,O
104948,10,-,O
104948,10,[,O
104948,10,**Hospital1,O
104948,10,8**,O
104948,10,],O
104948,10,Discharge,O
104948,10,Diagnosis,O
104948,10,:,O
104948,10,Primary,O
104948,10,:,O
104948,10,Septic,O
104948,10,Shock,O
104948,10,Community,O
104948,10,Aquired,O
104948,10,Pneumonia,O
104948,10,Respiratory,O
104948,10,Failure,O
104948,10,Acute,O
104948,10,Renal,O
104948,10,Failure,O
104948,10,Septic,O
104948,10,Arthritis,O
104948,10,(,O
104948,10,L,O
104948,10,Knee,O
104948,10,),O
104948,10,Bacteremia,O
104948,10,Infected,O
104948,10,R,O
104948,10,Chest,O
104948,10,Catheter,O
104948,10,Afib,O
104948,10,with,O
104948,10,RVR,O
104948,10,Delerium,O
104948,10,Anemia,O
104948,10,Thrombocytopenia,O
104948,10,Hyperglycemia,O
104948,10,Pneumothorax,O
104948,10,(,O
104948,10,R,O
104948,10,),O
104948,10,Hypokalemia,O
104948,10,Transaminitis,O
104948,10,Secondary,O
104948,10,:,O
104948,10,#,O
104948,10,Grade,O
104948,10,4,O
104948,10,glioblastoma,O
104948,10,multiforme,O
104948,10,left,O
104948,10,temporal,O
104948,10,lobe,O
104948,10,;,O
104948,10,s/p,O
104948,10,high,O
104948,10,dose,O
104948,10,radiotherapy,O
104948,10,",",O
104948,11,previously,O
104948,11,on,O
104948,11,high,O
104948,11,dose,O
104948,11,steroids,B-Drug
104948,11,",",O
104948,11,recently,O
104948,11,tapered,O
104948,11,.,O
104948,11,Recently,O
104948,11,placed,O
104948,11,Portacath,O
104948,11,with,O
104948,11,steristrips,O
104948,11,still,O
104948,11,present,O
104948,11,.,O
104948,11,#,O
104948,11,Rheumatoid,B-Reason
104948,11,arthritis,I-Reason
104948,11,;,O
104948,11,on,O
104948,11,remicade,B-Drug
104948,11,until,O
104948,11,recently,O
104948,11,#,O
104948,11,L,O
104948,11,knee,O
104948,11,bursitis,O
104948,11,#,O
104948,11,Hyperlipidemia,O
104948,11,Discharge,O
104948,11,Condition,O
104948,11,:,O
104948,11,fair,O
104948,11,-,O
104948,11,multifactorial,O
104948,11,delirium,O
104948,11,with,O
104948,11,waxing,O
104948,11,and,O
104948,11,[,O
104948,11,**Doctor,O
104948,11,Last,O
104948,11,Name,O
104948,11,688**,O
104948,11,],O
104948,11,mental,O
104948,11,status,O
104948,11,A+Ox1-2,O
104948,11,Discharge,O
104948,11,Instructions,O
104948,11,:,O
104948,11,You,O
104948,11,were,O
104948,11,admitted,O
104948,11,for,O
104948,11,pneumonia,B-Reason
104948,11,and,O
104948,11,multiple,B-Reason
104948,11,infections,I-Reason
104948,11,including,O
104948,11,of,O
104948,11,your,O
104948,11,knee,O
104948,11,and,O
104948,11,blood,O
104948,11,stream,O
104948,11,.,O
104948,11,you,O
104948,11,were,O
104948,11,treated,O
104948,11,with,O
104948,11,several,O
104948,11,antibiotics,B-Drug
104948,11,and,O
104948,11,had,O
104948,11,a,O
104948,11,stay,O
104948,11,in,O
104948,11,the,O
104948,11,intensive,O
104948,11,care,O
104948,11,unit,O
104948,11,which,O
104948,11,required,O
104948,11,intubation,O
104948,11,.,O
104948,11,Currently,O
104948,11,you,O
104948,11,are,O
104948,11,being,O
104948,11,treated,O
104948,11,for,O
104948,11,these,O
104948,11,infections,O
104948,11,and,O
104948,11,are,O
104948,11,on,O
104948,11,tube,O
104948,11,feedings,O
104948,11,and,O
104948,11,slowly,O
104948,11,eating,O
104948,11,again,O
104948,11,.,O
104948,11,Regarding,O
104948,11,your,O
104948,11,brain,O
104948,11,tumor,O
104948,11,",",O
104948,11,we,O
104948,11,felt,O
104948,11,that,O
104948,11,this,O
104948,11,issue,O
104948,11,",",O
104948,11,while,O
104948,11,serious,O
104948,11,",",O
104948,11,was,O
104948,11,stable,O
104948,11,during,O
104948,11,your,O
104948,11,stay,O
104948,11,here,O
104948,11,.,O
104948,11,It,O
104948,11,is,O
104948,11,very,O
104948,11,important,O
104948,11,that,O
104948,11,you,O
104948,11,followup,O
104948,11,with,O
104948,11,your,O
104948,11,neuro-oncologist,O
104948,11,Dr.,O
104948,11,[,O
104948,11,**Last,O
104948,11,Name,O
104948,11,(,O
104948,11,STitle,O
104948,11,),O
104948,11,**,O
104948,11,],O
104948,11,at,O
104948,11,[,O
104948,11,**Hospital1,O
104948,11,2025**,O
104948,11,],O
104948,11,.,O
104948,11,You,O
104948,11,need,O
104948,11,to,O
104948,11,discuss,O
104948,11,with,O
104948,11,him,O
104948,11,whether,O
104948,11,you,O
104948,11,should,O
104948,11,be,O
104948,11,on,O
104948,11,blood,B-Drug
104948,11,thinners,I-Drug
104948,11,.,O
104948,11,.,O
104948,11,Followup,O
104948,11,Instructions,O
104948,11,:,O
104948,11,f/u,O
104948,11,with,O
104948,11,Dr.,O
104948,11,[,O
104948,11,**First,O
104948,11,Name11,O
104948,11,(,O
104948,11,Name,O
104948,11,Pattern1,O
104948,11,),O
104948,11,**,O
104948,11,],O
104948,11,[,O
104948,11,**Initial,O
104948,11,(,O
104948,11,NamePattern1,O
104948,11,),O
104948,11,**,O
104948,11,],O
104948,11,[,O
104948,11,**Last,O
104948,11,Name,O
104948,11,(,O
104948,11,NamePattern1,O
104948,11,),O
104948,11,1005**,O
104948,11,],O
104948,11,of,O
104948,11,orthopedic,O
104948,11,surgery,O
104948,11,at,O
104948,11,(,O
104948,11,[,O
104948,11,**Telephone/Fax,O
104948,11,(,O
104948,11,1,O
104948,11,),O
104948,11,15940**,O
104948,11,],O
104948,11,to,O
104948,11,schedule,O
104948,11,a,O
104948,11,followup,O
104948,11,appointment,O
104948,11,in,O
104948,11,1,O
104948,11,month,O
104948,11,.,O
104948,11,f/u,O
104948,11,with,O
104948,11,your,O
104948,11,outpatient,O
104948,11,rheumatologist,O
104948,11,in,O
104948,11,[,O
104948,11,**1-6**,O
104948,11,],O
104948,11,weeks,O
104948,11,.,O
104948,11,f/u,O
104948,11,with,O
104948,11,your,O
104948,11,outpatient,O
104948,11,neurooncologist,O
104948,11,Dr.,O
104948,11,[,O
104948,11,**Last,O
104948,11,Name,O
104948,11,(,O
104948,11,STitle,O
104948,11,),O
104948,11,**,O
104948,11,],O
104948,11,on,O
104948,11,Monday,O
104948,11,by,O
104948,11,phone,O
104948,11,-,O
104948,11,he,O
104948,11,should,O
104948,11,be,O
104948,11,involved,O
104948,11,in,O
104948,11,deciding,O
104948,11,steroid,O
104948,11,taper,O
104948,11,and,O
104948,11,deciding,O
104948,11,about,O
104948,11,anticoagulation,O
104948,11,.,O
104948,11,Some,O
104948,11,of,O
104948,11,your,O
104948,11,labs,O
104948,11,will,O
104948,11,be,O
104948,11,faxed,O
104948,11,to,O
104948,11,Dr.,O
104948,11,[,O
104948,11,**First,O
104948,11,Name4,O
104948,11,(,O
104948,11,NamePattern1,O
104948,11,),O
104948,11,**,O
104948,11,],O
104948,11,[,O
104948,11,**Last,O
104948,11,Name,O
104948,11,(,O
104948,11,NamePattern1,O
104948,11,),O
104948,11,**,O
104948,11,],O
104948,11,of,O
104948,11,infectious,O
104948,11,disease,O
104948,11,at,O
104948,11,(,O
104948,11,[,O
104948,11,**Telephone/Fax,O
104948,11,(,O
104948,11,1,O
104948,11,),O
104948,11,1353**,O
104948,11,],O
104948,11,(,O
104948,11,phone,O
104948,12,(,O
104948,12,[,O
104948,12,**Telephone/Fax,O
104948,12,(,O
104948,12,1,O
104948,12,),O
104948,12,17490**,O
104948,12,],O
104948,12,),O
104948,12,",",O
104948,12,she,O
104948,12,will,O
104948,12,contact,O
104948,12,you,O
104948,12,regarding,O
104948,12,followup,O
104948,12,.,O
